Targeting Intracellular WT1 in AML Utilizing a T Cell Bispecific Antibody Construct: Augmenting Efficacy through Combination with Lenalidomide

Antibody-based immunotherapy represents a promising strategy to target chemo-resistant leukemic cells. However, current antibody-based approaches are restricted to cell lineage surface antigens. Targeting intracellular antigens enables to enlarge the number of suitable tumor-associated target antige...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 134; no. Supplement_1; p. 4450
Main Authors Klein, Christian, Augsberger, Christian, Xu, Wei, Heitmüller, Christina, Hanisch, Lydia, Sam, Johannes, Pulko, Vesna, Schönle, Anne, Challier, John, Carpy, Alejandro, Konstandin, Nikola, Rothe, Maurine, Hänel, Gerulf, Bücklein, Veit, Lichtenegger, Felix S., Tunger, Antje, Schmitz, Marc, von Bergwelt, Michael, Spiekermann, Karsten, Umana, Pablo, Subklewe, Marion
Format Journal Article
LanguageEnglish
Published Elsevier Inc 13.11.2019
Online AccessGet full text

Cover

Loading…